Nutrien Ltd. (NTR)
NYSE: NTR · Real-Time Price · USD
68.68
+1.46 (2.17%)
At close: Jan 21, 2026, 4:00 PM EST
69.31
+0.63 (0.92%)
Pre-market: Jan 22, 2026, 5:42 AM EST
Nutrien Stock Forecast
Stock Price Forecast
The 20 analysts that cover Nutrien stock have a consensus rating of "Hold" and an average price target of $65.3, which forecasts a -4.92% decrease in the stock price over the next year. The lowest target is $53 and the highest is $77.
Price Target: $65.3 (-4.92%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Nutrien stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 6 |
| Hold | 10 | 10 | 10 | 10 | 10 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 17 | 17 | 17 | 17 | 17 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $70 → $75 | Buy | Maintains | $70 → $75 | +9.20% | Jan 20, 2026 |
| Mizuho | Mizuho | Hold Maintains $65 → $68 | Hold | Maintains | $65 → $68 | -0.99% | Jan 16, 2026 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $70 → $77 | Hold → Buy | Upgrades | $70 → $77 | +12.11% | Jan 14, 2026 |
| UBS | UBS | Hold Maintains $58 → $63 | Hold | Maintains | $58 → $63 | -8.27% | Jan 12, 2026 |
| Mizuho | Mizuho | Hold Maintains $61 → $65 | Hold | Maintains | $61 → $65 | -5.36% | Dec 18, 2025 |
Financial Forecast
Revenue This Year
26.63B
from 25.02B
Increased by 6.44%
Revenue Next Year
26.94B
from 26.63B
Increased by 1.16%
EPS This Year
4.76
from 1.36
Increased by 250.23%
EPS Next Year
4.79
from 4.76
Increased by 0.60%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 28.5B | 29.9B | ||||
| Avg | 26.6B | 26.9B | ||||
| Low | 25.4B | 25.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.7% | 12.2% | ||||
| Avg | 6.4% | 1.2% | ||||
| Low | 1.7% | -5.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.99 | 6.14 | ||||
| Avg | 4.76 | 4.79 | ||||
| Low | 4.43 | 3.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 340.1% | 29.0% | ||||
| Avg | 250.2% | 0.6% | ||||
| Low | 225.8% | -18.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.